financetom
Business
financetom
/
Business
/
NYSE names public policy veteran Bryan Daniel as president of NYSE Texas
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NYSE names public policy veteran Bryan Daniel as president of NYSE Texas
Aug 4, 2025 6:56 AM

Aug 4 (Reuters) - The New York Stock Exchange on Monday

named Bryan Daniel as the president of NYSE Texas, adding

political experience to its leadership ranks as it seeks to

expand in the state and counter rivals.

His background in public policy could be key as NYSE works

to strengthen its presence in a state that hosts the largest

number of companies listed on the exchange.

Daniel is the chair of the Texas Workforce Commission, which

oversees and provides workforce development services to

employers and job seekers of the Lone Star State.

Prior to that, he was also part of Texas Governor Greg

Abbott's senior staff.

Daniel will report to Lynn Martin, president of the NYSE

Group, the company said.

Intercontinental Exchange ( ICE )-owned NYSE has scored some

key wins recently, with AT&T ( T ) and Trump Media & Technology

Group ( DJT ) opting to dual list on NYSE Texas.

Its biggest rival Nasdaq, however, is also

sharpening focus on the state, with plans to open a regional

headquarters there.

Besides, a new venture backed by heavyweights such as

BlackRock ( BLK ) and Citadel Securities, called the Texas Stock

Exchange, is gearing up for a launch next year.

The fierce competition highlights the growth of the state as

a financial hub and a challenger to New York. Corporate giants,

including Elon Musk's Tesla and SpaceX, have moved

their headquarters to Texas in recent years, drawn by what they

view as a more business-friendly legal and regulatory climate.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bath & Body Works' Fiscal Q3 Adjusted Earnings, Net Sales Fall; Revises Fiscal Full-Year Guidance
Bath & Body Works' Fiscal Q3 Adjusted Earnings, Net Sales Fall; Revises Fiscal Full-Year Guidance
Nov 20, 2025
07:35 AM EST, 11/20/2025 (MT Newswires) -- Bath & Body Works ( BBWI ) reported fiscal Q3 adjusted earnings Thursday of $0.35 per diluted share, compared with $0.49 a year earlier. Analysts polled by FactSet expected $0.39. Net sales for the quarter ended Nov.1 were $1.59 billion, compared with $1.61 billion a year earlier. Analysts surveyed by FactSet expected $1.63...
Top Premarket Gainers
Top Premarket Gainers
Nov 20, 2025
07:35 AM EST, 11/20/2025 (MT Newswires) -- PACS Group ( PACS ) shares were 40% higher pre-bell Thursday, a day after the company reported higher Q3 earnings and revenue. Cerence ( CRNC ) stock was up 30% after the company reported late Wednesday improved fiscal Q4 financial results. Magnera ( MAGN ) shares were 20% higher, a day after the...
Abbott Laboratories to Acquire Exact Sciences for $21 Billion
Abbott Laboratories to Acquire Exact Sciences for $21 Billion
Nov 20, 2025
07:37 AM EST, 11/20/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) said Thursday it has entered into a definitive agreement to acquire Exact Sciences ( EXAS ) for a total equity value of about $21 billion, or $105 per common share. The deal is expected to close in Q2 of 2026 and is subject to the approval of Exact...
Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences
Abbott bolsters diagnostics portfolio with up to $23 billion buyout of Exact Sciences
Nov 20, 2025
(Reuters) -Abbott said on Thursday it would buy cancer test maker Exact Sciences ( EXAS ) in a deal valued at up to $23 billion, including debt, marking one of its largest acquisitions in nearly a decade and its first major push into cancer screening. The deal will add Exact Sciences' ( EXAS ) flagship colorectal cancer test Cologuard and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved